These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 14533126

  • 1. Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia.
    Aarsland D, Hutchinson M, Larsen JP.
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):937-41. PubMed ID: 14533126
    [Abstract] [Full Text] [Related]

  • 2. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
    Minett TS, Thomas A, Wilkinson LM, Daniel SL, Sanders J, Richardson J, Littlewood E, Myint P, Newby J, McKeith IG.
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies.
    Thomas AJ, Burn DJ, Rowan EN, Littlewood E, Newby J, Cousins D, Pakrasi S, Richardson J, Sanders J, McKeith IG.
    Int J Geriatr Psychiatry; 2005 Oct; 20(10):938-44. PubMed ID: 16163744
    [Abstract] [Full Text] [Related]

  • 4. Clinical predictors of response to Acetyl Cholinesterase Inhibitors: experience from routine clinical use in Newcastle.
    Pakrasi S, Mukaetova-Ladinska EB, McKeith IG, O'Brien JT.
    Int J Geriatr Psychiatry; 2003 Oct; 18(10):879-86. PubMed ID: 14533120
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)].
    Litvinenko IV, Odinak MM, Mogil'naia VI, Emelin AIu.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007 Oct; 107(12):25-33. PubMed ID: 18427456
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
    Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, Pasquier F, Johnson S.
    Dement Geriatr Cogn Disord; 2007 Oct; 23(6):401-5. PubMed ID: 17409748
    [Abstract] [Full Text] [Related]

  • 7. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease.
    Leroi I, Brandt J, Reich SG, Lyketsos CG, Grill S, Thompson R, Marsh L.
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):1-8. PubMed ID: 14716693
    [Abstract] [Full Text] [Related]

  • 8. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW, Yik PY, Mok W, Chung CP.
    Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
    [Abstract] [Full Text] [Related]

  • 9. A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.
    Lee SW, Lee JG, Lee BJ, Kim YH.
    Int Clin Psychopharmacol; 2007 Mar; 22(2):63-8. PubMed ID: 17293705
    [Abstract] [Full Text] [Related]

  • 10. Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients.
    Grossi D, Trojano L, Pellecchia MT, Amboni M, Fragassi NA, Barone P.
    Int J Geriatr Psychiatry; 2005 Jul; 20(7):668-73. PubMed ID: 16021658
    [Abstract] [Full Text] [Related]

  • 11. Effects of galantamine in patients with mild Alzheimer's disease.
    Orgogozo JM, Small GW, Hammond G, Van Baelen B, Schwalen S.
    Curr Med Res Opin; 2004 Nov; 20(11):1815-20. PubMed ID: 15537482
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson's disease (an open controlled trial).
    Litvinenko IV, Odinak MM, Mogil'naya VI, Emelin AY.
    Neurosci Behav Physiol; 2008 Nov; 38(9):937-45. PubMed ID: 18975103
    [Abstract] [Full Text] [Related]

  • 13. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
    Freund-Levi Y, Jedenius E, Tysen-Bäckström AC, Lärksäter M, Wahlund LO, Eriksdotter M.
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):341-8. PubMed ID: 24035407
    [Abstract] [Full Text] [Related]

  • 14. Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
    Mega MS, Dinov ID, Porter V, Chow G, Reback E, Davoodi P, O'Connor SM, Carter MF, Amezcua H, Cummings JL.
    Arch Neurol; 2005 May; 62(5):721-8. PubMed ID: 15883258
    [Abstract] [Full Text] [Related]

  • 15. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.
    Vellas B, Cunha L, Gertz HJ, De Deyn PP, Wesnes K, Hammond G, Schwalen S, GAL-INT-28 Study Group.
    Curr Med Res Opin; 2005 Sep; 21(9):1423-9. PubMed ID: 16197661
    [Abstract] [Full Text] [Related]

  • 16. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
    Gurevich TY, Shabtai H, Korczyn AD, Simon ES, Giladi N.
    Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
    [Abstract] [Full Text] [Related]

  • 17. Galantamine for the treatment of BPSD in Thai patients with possible Alzheimer's disease with or without cerebrovascular disease.
    Tangwongchai S, Thavichachart N, Senanarong V, Poungvarin N, Phanthumchinda K, Praditsuwan R, Nidhinandana S, Chankrachang S.
    Am J Alzheimers Dis Other Demen; 2006 Oct; 23(6):593-601. PubMed ID: 18845693
    [Abstract] [Full Text] [Related]

  • 18. Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.
    Monsch AU, Giannakopoulos P, GAL-SUI Study Group.
    Curr Med Res Opin; 2004 Jun; 20(6):931-8. PubMed ID: 15200752
    [Abstract] [Full Text] [Related]

  • 19. [Galantamine therapy in dementia associated with CADASIL].
    Posada IJ, Ferrero M, Lopez-Valdes E, Goni-Imizcoz M.
    Rev Neurol; 2004 Jun; 47(6):299-300. PubMed ID: 18803156
    [Abstract] [Full Text] [Related]

  • 20. Clinical experience of galantamine in dementia: a series of case reports.
    Dale MC, Libretto SE, Patterson C, Anderson J, Choudhury T, McCafferty F, McWilliam C, Richardson M.
    Curr Med Res Opin; 2003 Jun; 19(6):508-18. PubMed ID: 14594523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.